PANSS (Positive and Negative Syndrome Scale)

The PANSS is a 30-item clinician-administered scale for rating the severity of schizophrenia. Three subscales, Positive, Negative, and General Psychopathology, each use a 1–7 severity anchor. The criterion standard for antipsychotic clinical trials since 1987.

What is the PANSS?

The Positive and Negative Syndrome Scale (PANSS) was developed by Stanley R. Kay, Abraham Fiszbein, and Lewis A. Opler and published in 1987. It was designed to address limitations of earlier schizophrenia rating scales by providing balanced, operationally defined assessments of both positive symptoms (hallucinations, delusions, disorganization) and negative symptoms (blunted affect, alogia, avolition), alongside a broad general psychopathology subscale.

The PANSS requires a structured clinical interview of 30–40 minutes. Clinicians rate each of the 30 items on a 7-point anchored scale: 1 = absent, 2 = minimal, 3 = mild, 4 = moderate, 5 = moderate-severe, 6 = severe, 7 = extreme. Because all items begin at 1 (not 0), the minimum possible total score is 30 and the theoretical maximum is 210. The three subscale minimums are 7 (Positive), 7 (Negative), and 16 (General Psychopathology).

The PANSS has become the de facto standard outcome measure in phase II and III antipsychotic clinical trials globally. It is psychometrically strong, with well-documented reliability and validity across multiple languages and clinical settings. Beyond schizophrenia, it is used in studies of schizoaffective disorder, bipolar disorder with psychotic features, and other psychotic spectrum conditions. Longitudinal tracking of PANSS subscale scores is central to measurement-based care for psychotic disorders.

Positive Subscale (P)

7 items: delusions, conceptual disorganization, hallucinatory behavior, excitement, grandiosity, suspiciousness/persecution, hostility. Score range 7–49.

Negative Subscale (N)

7 items: blunted affect, emotional withdrawal, poor rapport, passive/apathetic social withdrawal, difficulty in abstract thinking, lack of spontaneity, stereotyped thinking. Score range 7–49.

General Psychopathology (G)

16 items covering somatic concern, anxiety, guilt, tension, mannerisms, depression, motor retardation, uncooperativeness, unusual thought content, disorientation, poor attention, judgment, disturbance of volition, poor impulse control, preoccupation, active social avoidance. Score range 16–112.

PANSS Score Interpretation

Total score severity bands used in clinical trials and published norms. Subscale scores are evaluated independently alongside the total.

Subscale Score Ranges

*Andreasen et al. (2005) remission criteria require 8 key PANSS items ≤3 for 6 months.

Enter subscale totals from a completed PANSS interview to calculate the total score and severity band.

Subscale Breakdown

Educational reference only. Cannot replace clinical evaluation or a full structured PANSS interview.

Positive vs Negative Symptoms

A key clinical utility of the PANSS is tracking positive and negative subscales independently, as they respond differently to antipsychotic treatment.

Positive symptoms represent excesses or distortions of normal function: hallucinations, delusions, disorganized thinking, and agitation. They tend to respond well to first- and second-generation antipsychotics and are often the presenting features in acute psychotic episodes.

In clinical trials, a 20–30% reduction in total PANSS score (with Positive subscale improvement) is commonly used as the threshold for treatment response.

Negative symptoms reflect deficits: blunted affect, poverty of speech, avolition, anhedonia, and social withdrawal. They are associated with poorer functional outcomes and remain more resistant to pharmacological treatment than positive symptoms.

Separate tracking of the Negative subscale is essential for evaluating novel antipsychotic agents and for guiding psychosocial rehabilitation planning alongside medication management.

Track PANSS Subscales Longitudinally in HiBoop

Automated subscale scoring, positive/negative trend visualization, and clinical documentation for every patient, PANSS alongside CGI, BPRS, and more.